Judge:  Drug Company's Alleged Misstatements In Stock-Drop Suit Not Actionable

Mealey's (July 28, 2020, 1:37 PM EDT) -- BOSTON — Statements issued by a pharmaceutical company and certain current and former executive officers regarding the timing of topline results for a Phase 3 clinical test for a renal cancer...
To view the full article, register now.